Owlet Q1 Revenue Hits $22.5M, Exceeds Expectations
Reports Q1 revenue $22.5M, consensus $20.8M. "I am reassuming the CEO role to build on the mission I started 12 years ago, with a clear, long-term mandate to lead Owlet through its next phase of scale and development in pediatric health," said Kurt Workman, Owlet's President, Chief Executive Officer, and Co-Founder. "While our core mission hasn't changed, we are prioritizing our highest value opportunities to drive long-term stakeholder value, while sharpening our focus on business execution and operating efficiency. We are making significant strides in our evolution into a comprehensive pediatric health and data platform. Our Owlet360 subscription engine is thriving, scaling to over 115,000 paying subscribers to end the first quarter, and we are excited to announce the official release in our app of Owlet's OnCall pediatric telehealth service. We believe that combining insights from our platform with access to pediatric consultation will provide greater value to parents, simplify access to care, and lengthen the customer relationship. Looking ahead, we are concentrating our resources to capture the significant white space available in our current high-value markets. With a sharpened focus, disciplined financial strategy, and a clear roadmap to take the business to the next level, I have total confidence in Owlet's path as we scale our pediatric health platform and strive to build the standard for at-home infant care."
Trade with 70% Backtested Accuracy
Analyst Views on OWLT
About OWLT
About the author

- Ecosystem Expansion: Owlet has launched Dream Sight and Dream Duo 3 in Australia and New Zealand, building on the success of Dream Sock to provide local families with a complete monitoring ecosystem for the first time, which is expected to significantly enhance market share and brand influence.
- Technological Innovation and Security: Dream Sight, as the next-generation 2K HD monitor, features night vision, a 130-degree wide-angle lens, and 256-bit encryption technology, ensuring user data security and further solidifying Owlet's leadership in the smart infant monitoring sector.
- User Feedback and Market Demand: A 2017 survey indicated that 96% of users reported reduced anxiety and 94% improved sleep quality after using Owlet products, demonstrating the effectiveness of Owlet's offerings in meeting parental needs and enhancing infant health monitoring.
- Strategic Market Positioning: Through this product launch, Owlet strengthens its market penetration in the Asia-Pacific region, which is expected to attract more families to focus on infant health monitoring, driving future growth and innovation for the company.
- Leadership Transition: Kurt Workman returns as CEO, emphasizing a focus on subscription and telehealth, indicating a strategic shift aimed at enhancing long-term profitability and operational execution.
- Revenue Guidance Adjustment: Owlet revised its 2026 revenue guidance to a range of $118 million to $122 million, down from $126 million to $130 million, reflecting a cautious outlook on market demand while raising adjusted EBITDA expectations to $7 million to $9 million, highlighting a focus on profitability.
- Financial Performance: Q1 total revenue reached $22.5 million, exceeding the guidance of $20 million to $21 million, with a gross margin of 54.5%; however, adjusted EBITDA was negative $1.5 million, indicating ongoing cost pressures despite subscription growth.
- Market Strategy Contraction: The company has decided to defer entry into markets like India, Hong Kong, and Singapore, reallocating resources to core markets for higher near-term returns, reflecting a cautious approach to resource allocation and market dynamics.
- Award Recognition: Owlet's Dream Duo 3 has been named 'Best for Monitoring Baby's Health' in the PARENTS 2026 Best for Baby Awards, enhancing brand visibility and solidifying its leadership position in the smart infant monitoring sector.
- Technological Innovation: The Dream Duo 3 combines the FDA-cleared Dream Sock® and SGS Cybersecurity-certified Dream Sight™, enabling real-time tracking of pulse, oxygen levels, and sleep patterns, significantly enhancing parents' insights into their baby's health.
- User Trust: Trusted by over 2.5 million families, Owlet's platform has amassed one of the largest pediatric health datasets globally, providing robust data support for future product innovations and further strengthening the company's competitive edge in the market.
- Market Availability: Dream Duo 3 is now available at www.owletcare.com and major retailers worldwide, including Walmart and Amazon, which is expected to further expand market share and enhance consumer purchasing convenience.
- Oversold Signal: Owlet Inc (Ticker: OWLT) saw its RSI drop to 29.7 during Monday's trading, indicating an oversold condition with shares hitting a low of $5, suggesting that recent heavy selling may be nearing exhaustion and providing potential buying opportunities for bullish investors.
- Market Comparison: Compared to the current RSI of 47.6 for the S&P 500 ETF (SPY), OWLT's low RSI reflects relative weakness in the market, which may attract investors looking for a rebound.
- Historical Performance: OWLT's 52-week low stands at $2.75 per share, with a high of $16.94, while the last trade was at $5.10, indicating significant price volatility that investors might consider for trading within this range.
- Investor Sentiment: While the current oversold condition may attract some investors, caution is advised in assessing market trends to avoid impulsive decisions in an uncertain environment.
- Earnings Highlights: Owlet reported Q1 revenue of $26.6 million, a 29.6% year-over-year increase, surpassing market expectations of $26 million, although gross profit rose to $12.6 million, the gross margin fell by 596 basis points to 47.6% due to tariff impacts.
- Adjusted EBITDA Decline: The adjusted EBITDA stood at $0.1 million, significantly down from $0.5 million in the same quarter last year, indicating challenges in cost management that could affect future profitability.
- Disappointing Outlook: The company expects Q1 2026 revenue between $20 million and $21 million, below the consensus of $26.204 million, reflecting a cautious outlook on market demand that may lead to decreased investor confidence.
- Long-term Revenue Projections: Owlet projects 2026 full-year revenue of $126 million to $130 million, slightly below the market view of $128.073 million, with gross margins expected between 49% and 52%, indicating that tariff impacts will remain a significant concern.
- Deteriorating Market Sentiment: The CNN Money Fear & Greed Index recorded a reading of 26.7 on Friday, indicating a persistent state of 'Fear' in the market, down from 28.3 previously, reflecting investor anxiety about future market conditions.
- Significant Stock Market Decline: The Dow Jones dropped over 450 points to close at 47,501.55, while the S&P 500 fell 1.33% to 6,740.02, and the Nasdaq Composite declined 1.59%, showcasing overall market weakness and investor pessimism.
- Weak Economic Data: U.S. retail sales fell by 0.2% month-over-month in January, missing the market estimate of a 0.3% decline, and the nonfarm payrolls decreased by 92,000 in February 2026, with the unemployment rate rising to 4.4%, indicating heightened risks of economic slowdown.
- Oil Price Surge Risks: Qatar's energy minister warned that oil prices could surge past $150 if the Strait of Hormuz were to close completely, with crude prices rallying nearly 35% this week, marking the largest weekly gain in commodity trading history, which could have profound implications for the global economy.










